2013 News

Oxford BioTherapeutics and Menarini Progress Enhanced Antibody for Acute Myeloid Leukemia in $1 Billion Oncology Investment Alliance

OXFORD, UK and BERLIN CHEMIE/MENARINI, GERMANY – 9th December 2013 – Oxford BioTherapeutics (OBT) and Berlin-Chemie (Menarini Group) announce today that they have designated a novel enhanced antibody targeting acute myeloid leukemia...

Zysis Receives US Patent for Long Acting Oral Aripiprazole Once Weekly

Portfolio company Zysis, a private pharmaceutical company optimising therapies for disorders of the Central Nervous System, today announced that the United States Patent and Trademark Office has granted U.S. patent 8,575,172 covering its Phase I...

Technology Strategy Board awards Accutronics £100,000 for medical battery

Portfolio company Accutronics has received a Smart Award from the UK’s innovation agency, the Technology Strategy Board. The company received a £100,000 grant to support ‘proof of concept’ work on a new high voltage...

Patent Published for Lumora’s Novel Sample Preparation Technology

Cambridgeshire, UK, 31 October 2013 ... Lumora, a provider of state-of-the-art molecular diagnostic products for the clinical and industrial market, has received a patent for its Heat Elution Sample Preparation, technology which has the potentia...

PolyTherics and TUBE Pharma collaborate to develop novel cytotoxic payloads for antibody drug conjugates (ADCs)

London, UK and Vienna, Austria, 15 October 2013 - PolyTherics Limited (“PolyTherics”) and TUBE Pharma GmbH (“TUBE”) announce that they are collaborating to produce reagents to link novel cytotoxic drugs developed by TUBE...

From our portfolio

Abzena plc

Healthcare

Abzena offers product specific licences and services for the application of conjugation and polym...

viewview our portfolio

Our Team

Nick Wright

view complete team

Contact us

Binder House
7 Narborough Wood Park
Desford Road
Enderby
Leicester
LE19 4XT

Tel: 0116 238 8200

email